B lymphocytes are activated and regulated by their interactions with T cells, a process that results in one-way class switching of immunoglobulins (ig) from IgM to IgG, IgE, or IgA. In this study, we show the application of clustered regularly interspaced short palindromic repeat-Cas9-induced nonhomologous end joining in B cells to achieve reverse-directional Ig class switching. By electroporating Cas9 and guide RNA and a Cμ encoding donor into cells, we engineered IgG-secreting human B cell lines to switch to express IgM antibody. This approach offers a new potential path for the production of IgM antibodies.
Get full access to this article
View all access options for this article.
References
1.
StavnezerJ, GuikemaJE, SchraderCE. Mechanism and regulation of class switch recombination. Annu Rev Immunol, 2008; 26:261–292; doi: 10.1146/annurev.immunol.26.021607.090248.
2.
OudinetC, BraikiaFZ, DaubaA, et al.Mechanism and regulation of class switch recombination by IgH transcriptional control elements. Adv Immunol, 2020; 147:89–137; doi: 10.1016/bs.ai.2020.06.003.
3.
CongL, RanFA, CoxD, et al.Multiplex genome engineering using CRISPR/Cas systems. Science, 2013; 339:819–823; doi: 10.1126/science.1231143.
4.
MaliP, YangL, EsveltKM, et al.RNA-guided human genome engineering via Cas9. Science, 2013; 339:823–826; doi: 10.1126/science.1232033.
5.
WangH, YangH, ShivalilaCS, et al.One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell, 2013; 153:910–918; doi: 10.1016/j.cell.2013.04.025.
6.
PaquetD, KwartD, ChenA, et al.Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature, 2016; 533:125–129; doi: 10.1038/nature17664.
7.
AuerTO, DuroureK, De CianA, et al.Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. Genome Res, 2014; 24:142–153; doi: 10.1101/gr.161638.113.
8.
HeX, TanC, WangF, et al.Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair. Nucleic Acids Res, 2016; 44:e85; doi: 10.1093/nar/gkw064.
9.
SuzukiK, TsunekawaY, Hernandez-BenitezR, et al.In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration. Nature, 2016; 540:144–149; doi: 10.1038/nature20565.
10.
LinG, ZhangK, PengR, et al.Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated endonuclease Cas9-mediated homology-independent integration for generating quality control materials for clinical molecular genetic testing. J Mol Diagn, 2018; 20:373–380; doi: 10.1016/j.jmoldx.2018.02.002
11.
ArtegianiB, HendriksD, BeumerJ, et al.Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing. Nat Cell Biol, 2020; 22:321–331; doi: 10.1038/s41556-020-0472-5.
12.
HungKL, MeitlisI, HaleM, et al.Engineering protein-secreting plasma cells by homology-directed repair in primary human B cells. Mol. Ther, 2018; 26:456–467; doi: 10.1016/j.ymthe.2017.11.012.
13.
WuCM, RothTL, BaglaenkoY, et al.Genetic engineering in primary human B cells with CRISPR-Cas9 ribonucleoproteins. J Immunol Methods, 2018; 457:33–40; doi: 10.1016/j.jim.2018.03.009.
14.
HartwegerH, McGuireAT, HorningM, et al.HIV-specific humoral immune responses by CRISPR/Cas9-edited B cells. J Exp Med, 2019; 216:1301–1310; doi: 10.1084/jem.20190287.
15.
MoffettHF, HarmsCK, FitzpatrickKS, et al.B cells engineered to express pathogen-specific antibodies protect against infection. Sci Immunol, 2019; 4:eaax0644; doi: 10.1126/sciimmunol.aax0644.
16.
VossJE, Gonzalez-MartinA, AndrabiR, et al.Reprogramming the antigen specificity of B cells using genome-editing technologies. eLife, 2019; 8; doi: 10.7554/eLife.42995.
17.
LuoB, ZhanY, LuoM, et al.Engineering of alpha-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis, 2020; 11:973; doi: 10.1038/s41419-020-03187-1.
18.
NahmadAD, RavivY, Horovitz-FriedM, et al.Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion. Nat Commun, 2020; 11:5851; doi: 10.1038/s41467-020-19649-1.
19.
CheongTC, CompagnoM, ChiarleR. Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system. Nat Commun, 2016; 7:10934; doi: 10.1038/ncomms10934.
20.
MatthesT, KindlerV, ZublerRH. Semiquantitative, nonradioactive RT-PCR detection of immunoglobulin mRNA in human B cells and plasma cells. DNA Cell Biol, 1994; 13:429–436; doi: 10.1089/dna.1994.13.429.
21.
GuthmillerJJ, DuganHL, NeuKE, et al.An efficient method to generate monoclonal antibodies from human B cells. Methods Mol Biol, 2019; 1904:109–145; doi: 10.1007/978-1-4939-8958-4_5.
22.
CortiD, LanzavecchiaA. Efficient methods to isolate human monoclonal antibodies from memory B cells and plasma cells. Microbiol Spectr, 2014; 2; doi: 10.1128/microbiolspec.AID-0018-2014.
23.
SteinitzM. Production of human monoclonal antibodies by the epstein-barr virus method. Methods Mol Biol, 2014; 1060:111–122; doi: 10.1007/978-1-62703-586-6_6.
24.
KwakkenbosMJ, DiehlSA, YasudaE, et al.Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming. Nat Med, 2010; 16:123–128; doi: 10.1038/nm.2071.
25.
LyskiZL, MesserWB. Approaches to interrogating the human memory B-cell and memory-derived antibody repertoire following dengue virus infection. Front Immunol, 2019; 10:1276; doi: 10.3389/fimmu.2019.01276.
26.
KeytBA, BaligaR, SinclairAM, et al.Structure, function, and therapeutic use of IgM antibodies. Antibodies, 2020; 9(4):53; doi: 10.3390/antib9040053.
27.
JohnstonAD, Simoes-PiresCA, SuzukiM, et al.High-efficiency genomic editing in Epstein-Barr virus-transformed lymphoblastoid B cells using a single-stranded donor oligonucleotide strategy. Commun Biol, 2019; 2:312; doi: 10.1038/s42003-019-0559-3.
28.
XuX, GaoD, WangP, et al.Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation. Sci Rep, 2018; 8:11649; doi: 10.1038/s41598-018-30227-w.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
